Fig. 1

DHM inhibited cell proliferation and viability of Hep3B cells. A Hep3B cells were treated with six different doses of DHM (0 μM, 10 μM, 20 μM, 30 μM, 40 μM, 50 μM) of DHM for 24 h. Cell proliferation was examined by CCK-8 assays. B Effects of DHM and NDP on viability of Hep3B cells according to a colony formation assay. C Quantification of colonies number in the colony formation assay. Results are presented as mean ± standard error of mean (n ≥ 3). **P < 0.01 and ***P < 0.001 vs. control group or NDP group. DHM, Dihydromyricetin; NDP, Nedaplatin